There seems to be no causal association between COVID-19 and Guillain-Barré syndrome (GBS).
Exercise may benefit patients with idiopathic polyneuropathy and alleviate severe pain symptoms if done regularly.
Lower extremity MRI, including diffusion-tensor imaging, may provide valuable information on skeletal muscle abnormalities in patients with type 2 diabetes mellitus.
Low-frequency spinal cord stimulation (SCS) may be effective for treating painful diabetic neuropathy (DN).
Thalamic ventral posterior nucleus volume is associated with neuropathic pain intensity in patients with neuromyelitis optica spectrum disorders.
A standardized approach is vital for the assessment of neuropathic cancer pain in order to improve treatment results and future clinical/pre-clinical studies.
Nerve ultrasounds may be highly accurate in detecting chronic inflammatory neuropathies, as well as in predicting treatment response.
Hematologic and VEGF nonresponse, and therapy besides autologous stem cell transplantation are risk factors for POEMS progression.
Repeated transcranial direct current stimulation over 5 days was able to reduce pain intensity in patients with chronic neuropathic pain due to multiple sclerosis.
The FDA has approved Qutenza® for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet.